Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
OKYO Pharma Limited

OKYO Pharma Limited (OKYO) Stock Overview

Explore OKYO Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.

OKYO●NASDAQ
HealthcareBiotechnology
$1.64
$0.00(0.00%)
U.S. Market opens in 15h 54m

OKYO Pharma Limited (OKYO)

Meyka AI Score

Z

Key Financials

Market Cap62.9M
P/E Ratio-8.51
EPS (TTM)$-0.05
ROE-2.01%
Fundamental Analysis

AI Price Forecasts

1 Month$1.18
3 Months$0.50
1 Year Target$2.35

OKYO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of OKYO Pharma Limited (NASDAQ: OKYO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, OKYO Pharma Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OKYO on the NASDAQ shows an RSI of 55.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.35 for the NASDAQ listing.

Key metrics behind OKYO Pharma Limited's NASDAQ-traded stock include a P/E ratio of -8.51 and a market capitalization of 62.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OKYO on the NASDAQ.

Price Performance (NASDAQ: OKYO)

1-Day Change
N/A
5-Day Change
8.61%
1-Month Change
5.81%
3-Month Change
3.80%
6-Month Change
-25.11%
Year-to-Date (YTD) Change
-20.77%
1-Year Change
-39.93%
3-Year Change
-25.45%
5-Year Change
-54.70%
All-Time (Max) Change
-54.70%

Contact Information

https://www.okyopharma.com
44 20 7495 2379
55 Park Lane, London, GL, W1K 1NA

Company Facts

40 Employees
IPO DateMay 17, 2022
CountryGB
Actively Trading

Frequently Asked Questions